Clinical Trial Update: Study of ALTO-300 in MDD [Phase 2]

View source ↗

Summary

ALTO-300 is being studied in a Phase 2 clinical trial for major depressive disorder and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• ALTO-300

Snippet

Sponsor: Alto Neuroscience | Conditions: Major Depressive Disorder | Phase 2 | Status: RECRUITING